ALAB SEC Filings

Astera Labs, Inc. (ALAB) has filed a Form 8-K on August 4, 2026, to report its financial results for the second quarter ended June 30, 2026. The primary purpose of this filing is to furnish a press release detailing these results, which is included as Exhibit 99.1. While this information is publicly disclosed, it is important to note that, as per the filing, the content is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act, meaning it does not carry the same legal liabilities as formally filed documents. Investors should refer to the press release (Exhibit 99.1) for specific financial performance details and operational updates from the company during the reported quarter.

Astera Labs, Inc. (ALAB) filed an 8-K on June 8, 2026, detailing the results of its 2026 Annual Stockholders Meeting held on June 4, 2026. The meeting saw strong participation, with approximately 82.6% of the total outstanding shares being voted. Key outcomes include the re-election of all three Class II director nominees, overwhelmingly ratifying the appointment of PricewaterhouseCoopers LLP as the independent auditor, and approving executive compensation on an advisory basis (Say-on-Pay).

Astera Labs, Inc. reported robust financial performance for the first quarter of 2026, with significant year-over-year growth in revenue and profitability. Revenue more than doubled, reaching $308.4 million, a 93% increase compared to the same period in 2025, driven by strong demand for their Scorpio, Aries, and Taurus products and higher average selling prices. This revenue surge was accompanied by an expansion in gross margin to 76.3%, up from 74.9% in the prior year, attributed to a favorable product mix. Profitability saw substantial improvement, with operating income soaring by 448% to $61.8 million and net income increasing by 152% to $80.3 million. This strong operational performance was underpinned by strategic investments in research and development, which grew by 95% year-over-year, reflecting the company's commitment to innovation in its Intelligent Connectivity Platform. The company ended the quarter with a healthy liquidity position, holding $1.2 billion in cash, cash equivalents, and marketable securities, and generated a strong $74.6 million in cash flow from operations.

Astera Labs, Inc. (ALAB) filed an 8-K on May 5, 2026, primarily to furnish a press release detailing its financial results for the first quarter ended March 31, 2026. While the 8-K itself does not contain the specific financial figures, it directs investors to the attached press release (Exhibit 99.1) for these details. This filing is crucial for understanding the company's recent performance and outlook, as the press release likely includes key metrics such as revenue, profitability, and guidance for future periods. Investors should carefully review the furnished press release for a comprehensive understanding of Astera Labs' financial condition and operational results. The filing serves as a formal notification of the release of this information, which is important for making informed investment decisions. The company has also included the Cover Page Interactive Data File for enhanced data accessibility.

Astera Labs, Inc. (ALAB) demonstrated significant financial performance for the year ending December 31, 2025, with revenue soaring to $852.5 million, a substantial 115% increase from the prior year. This robust growth was driven by strong demand across its product lines, particularly Aries, Scorpio, and Taurus, alongside improved average selling prices. The company achieved a net income of $219.1 million, a dramatic turnaround from the net loss of $83.4 million in 2024, signaling strong operational improvements and market traction. Despite a slight decrease in gross margin to 75.7% due to a shift in product mix towards hardware modules, the company effectively managed operating expenses, which decreased by 7% year-over-year primarily due to a significant reduction in non-cash stock-based compensation. Astera Labs continues to invest heavily in research and development, with expenses increasing by 51% to support innovation in its Intelligent Connectivity Platform for cloud and AI infrastructure. The company's strong cash position and positive operating cash flow provide a solid foundation for continued growth and investment in its core technologies.

Astera Labs, Inc. (ALAB) announced on February 10, 2026, that it entered into a Transaction Agreement and a Warrant Agreement with Amazon.com, Inc. (Parent) and Amazon.com NV Investment Holdings LLC (Warrantholder), respectively, on February 5, 2026. This agreement allows for the issuance of a warrant to acquire up to approximately 3.26 million shares of common stock at an exercise price of $142.82 per share. The warrant is tied to performance conditions, specifically requiring Parent and its affiliates to purchase up to $6.5 billion of Astera Labs' smart fabric switch products, signal conditioning products, and optical engine products.

Astera Labs, Inc. (ALAB) has filed an 8-K report detailing a CFO transition. Effective March 2, 2026, Michael Tate will retire as Chief Financial Officer, moving into a Strategic Advisor role to the CEO until September 1, 2026. This transition appears smooth, with no stated disagreements and Tate remaining employed in an advisory capacity. Replacing Mr. Tate will be Desmond Lynch, who brings extensive financial leadership experience from companies like Rambus Inc. and Knowles Corporation. Mr. Lynch's appointment comes with a competitive compensation package, including a base salary of $500,000, a performance bonus target, and significant equity awards in the form of RSUs and PSUs, totaling $9 million in potential long-term incentives. This move signifies a deliberate effort to secure experienced financial leadership as the company progresses.

Astera Labs, Inc. (ALAB) has filed an 8-K report on February 10, 2026, to announce its financial results for the quarter and full year ended December 31, 2025. The core of this filing is the press release (Exhibit 99.1) containing these results, which is furnished and not deemed officially filed for regulatory liability purposes under Section 18 of the Exchange Act. Investors should refer to this press release for detailed financial performance metrics, including revenue, profitability, and any forward-looking guidance provided by the company. The furnishing of this press release via an 8-K is a standard disclosure mechanism for material financial updates. While the information itself is key, investors should note the specific legal treatment of this filing. The report also includes the standard XBRL interactive data file for enhanced data analysis. Any forward-looking statements or strategic commentary within the press release should be carefully considered by investors in the context of the company's overall business strategy and market conditions.

Astera Labs, Inc. has announced a key leadership change with the appointment of Germaine Cota as its new Chief Accounting Officer and Vice President of Finance, effective January 20, 2026. Ms. Cota brings extensive experience from her previous roles, including Senior Vice President of Finance & Accounting at BILL Holdings, Inc., and Chief Accounting Officer at 8x8, Inc., along with significant tenure at LinkedIn and Ernst & Young. This appointment is crucial for financial reporting and oversight as the company continues its growth trajectory. Investors should note the compensation package offered to Ms. Cota, which includes a base salary of $375,000, a performance bonus target of 50% of her base salary, a $130,000 hiring bonus (subject to clawback), and significant equity awards totaling $4,000,000 in restricted stock units. The equity awards are structured with a combination of immediate and phased vesting over several years, aligning Ms. Cota's incentives with the company's long-term performance and shareholder value.

Astera Labs, Inc. (ALAB) reported a strong third quarter of 2025, demonstrating significant year-over-year growth. Total revenue surged by 104% to $230.6 million for the three months ended September 30, 2025, and by 128% to $581.9 million for the first nine months of the year, primarily driven by increased unit shipments and a favorable product mix. The company achieved profitability in the current quarter and year-to-date, a significant turnaround from the previous year. This operational improvement is underpinned by robust demand for its Intelligent Connectivity Platform, serving hyperscalers and AI infrastructure needs. Despite increased operating expenses related to headcount growth and R&D initiatives, the company's strategic investments appear to be paying off, with a healthy increase in operating income and a positive net income of $91.1 million for the quarter.

Astera Labs, Inc. (ALAB) has filed an 8-K report on November 4, 2025, primarily to furnish a press release detailing its financial results for the quarter ended September 30, 2025. This filing provides investors with an update on the company's operational and financial performance. While the full financial details are contained within the furnished press release (Exhibit 99.1), this 8-K serves as the official notification of the release of this information to the market. Investors should refer to the press release for specific revenue, profitability, and any forward-looking guidance provided by the company.

Astera Labs, Inc. (ALAB) has announced a significant strategic move through a definitive agreement to acquire aiXscale Photonics GmbH, as detailed in an 8-K filing dated October 22, 2025. This acquisition is positioned to enhance Astera Labs' capabilities within the photonics and semiconductor sectors, likely bolstering its product portfolio and technological advancements, particularly in areas critical for AI and high-performance computing. Investors should monitor the integration process and the financial implications of this transaction closely, as it represents a substantial step in the company's growth strategy and market positioning.

Astera Labs, Inc. reported strong revenue growth in its fiscal second quarter of 2025, with a significant 150% increase year-over-year, driven by higher unit shipments and average selling prices across its Aries, Scorpio, and Taurus product lines. Despite this impressive top-line performance, the gross margin saw a slight decrease due to a shift in product mix towards hardware modules. The company also experienced a substantial increase in operating expenses, primarily due to growth in headcount and R&D initiatives aimed at supporting business expansion and product development. Financially, Astera Labs moved from a net loss in the prior year's comparable period to a substantial net income of $51.2 million for the quarter. This turnaround is further highlighted by the positive net cash provided by operating activities, a significant improvement from the previous year. The company maintains a strong liquidity position with over $1 billion in cash, cash equivalents, and marketable securities, which management believes is sufficient for at least the next 12 months. However, the report also notes material weaknesses in internal control over financial reporting, which the company is actively working to remediate.

Astera Labs, Inc. (ALAB) filed a Current Report on Form 8-K on August 5, 2025, primarily to furnish its press release detailing financial results for the quarter ended June 30, 2025. While the filing itself does not contain the detailed financial figures, it directs investors to the attached press release (Exhibit 99.1) for this crucial information. Investors should review this press release for performance metrics, revenue figures, profitability, and any forward-looking guidance provided by the company. The report clarifies that the information furnished is not deemed 'filed' for certain regulatory purposes, meaning it won't automatically be incorporated into other SEC filings unless specifically referenced. This 8-K serves as the official notification for the release of quarterly financial results. The key takeaway for investors is to access and analyze the accompanying press release. This document will contain the operational and financial condition updates for the period, which are essential for understanding the company's recent performance, its progress against expectations, and its outlook. Investors should pay close attention to any commentary on sales trends, product demand, and management's commentary on market conditions that may impact future results.

Astera Labs, Inc. (ALAB) filed an 8-K on June 10, 2025, detailing the results of its 2025 Annual Stockholders Meeting held on June 5, 2025. The key outcomes include the successful election of all three Class I director nominees and the ratification of PricewaterhouseCoopers LLP as the company's independent auditor for the fiscal year ending December 31, 2025. Investor turnout was robust, with approximately 87.6% of eligible shares represented at the meeting. The director elections and auditor ratification passed with significant majority support, indicating shareholder confidence in the current board and the company's financial oversight. This filing provides a snapshot of shareholder governance and affirms the company's chosen direction and auditing partner.

Astera Labs, Inc. (ALAB) has reported a strong first quarter for 2025, with a significant 144% year-over-year increase in revenue, reaching $159.4 million. This growth is primarily attributed to higher unit shipments of their Aries and Taurus product lines, coupled with an increased mix of hardware modules contributing to higher average selling prices. Despite the revenue surge, gross margin saw a slight decrease of 250 basis points to 74.9%, mainly due to the aforementioned product mix. The company has also demonstrated a considerable reduction in operating expenses, down 19% year-over-year. This was largely driven by a significant decrease in non-cash stock-based compensation expense following the IPO in the prior year. However, personnel-related expenses increased by 72% due to a substantial rise in headcount, alongside increased investments in research and development. Astera Labs has achieved profitability this quarter with a net income of $31.8 million, a stark contrast to the net loss reported in the same period last year.

Astera Labs, Inc. (ALAB) filed an 8-K on May 6, 2025, primarily to furnish a press release detailing its financial results for the quarter ended March 31, 2025. While the filing itself does not contain detailed financial tables, it directs investors to an accompanying press release (Exhibit 99.1) for the specific operational and financial performance metrics. Investors should consult this press release for information on revenue, profitability, and any forward-looking guidance provided by the company for the upcoming periods.

Astera Labs, Inc. (ALAB) announced a strategic addition to its Board of Directors, appointing Craig Barratt, effective March 2, 2025. The Board's size has been increased from seven to eight directors to accommodate this appointment. Dr. Barratt brings a wealth of experience in the semiconductor and technology sectors, having held significant leadership roles at Intel, Google, and Qualcomm, and previously served as CEO of Atheros Communications. This appointment is investor-focused as Dr. Barratt's deep industry expertise, particularly in connectivity and semiconductors, is expected to be highly valuable to Astera Labs as it navigates its growth phase. His role on the Audit Committee further strengthens the board's governance and oversight. The compensation details for Dr. Barratt, including an annual retainer, Audit Committee service fee, and a significant restricted stock unit (RSU) award, indicate alignment with his experience and the company's commitment to attracting top talent for its board.

Astera Labs, Inc. (ALAB) has demonstrated exceptional revenue growth in fiscal year 2024, with a 242% increase compared to 2023, reaching $396.3 million. This surge is primarily driven by increased unit shipments of their Aries products and a more favorable product mix leading to higher average selling prices. The company has also significantly improved its gross margin, climbing to 76.4% in 2024 from 68.9% in 2023, largely due to reduced inventory write-downs. Despite the strong top-line performance, Astera Labs continues to operate at a net loss, which widened in 2024 to $83.4 million from $26.3 million in 2023. This increased loss is significantly influenced by a substantial rise in operating expenses, particularly non-cash stock-based compensation, which surged by $223.1 million related to RSUs vesting upon their IPO. The company's robust cash position, bolstered by the March 2024 IPO which generated $672.2 million in net proceeds, provides ample liquidity to fund operations and future investments. Astera Labs expects its current cash resources to be sufficient for at least the next 12 months.

Astera Labs, Inc. (ALAB) filed an 8-K on February 10, 2025, to report its financial results for the fourth quarter and full fiscal year ended December 31, 2024. The key details of these results are presented in a press release furnished as Exhibit 99.1 to the filing. Investors should refer to this press release for specific financial performance metrics, including revenue, profitability, and any forward-looking guidance the company may have provided. This filing serves as the primary disclosure vehicle for the company's latest financial performance and condition.

Astera Labs, Inc. has entered into a material definitive agreement, a lease for approximately 154,231 square feet of office space in San Jose, California. This lease signifies a strategic move for the company, as it plans to relocate its corporate headquarters to this new location upon the completion of construction and the expiration of its current lease, expected in the second quarter of 2025. The new headquarters will support the company's growth and operational needs.

Astera Labs, Inc. (ALAB) has reported significant revenue growth in its Q3 2024 10-Q filing, with revenues increasing by 206% year-over-year for the three months ended September 30, 2024, and by 291% for the nine months ended September 30, 2024. This growth is primarily attributed to increased demand for its Aries products and a favorable product mix, including higher-selling second-generation retimers. The company also achieved a substantial improvement in gross margin, reaching 77.7% for both the three and nine-month periods, up from 76.1% and 62.5% in the prior year periods, respectively. This improvement is due to product mix, lower unit costs, and reduced inventory write-downs. Despite the strong revenue and gross profit performance, the company continues to operate at a net loss, reporting a net loss of $7.6 million for the third quarter and $108.1 million for the first nine months of 2024. This is largely driven by substantial increases in operating expenses, particularly R&D and SG&A, which saw significant jumps due to non-cash stock-based compensation expenses related to its IPO, and increased personnel costs from higher headcount. The company's cash position remains robust, bolstered by its March 2024 IPO, with cash, cash equivalents, and marketable securities totaling $886.8 million as of September 30, 2024.

Astera Labs, Inc. filed an 8-K on November 4, 2024, primarily to furnish its press release detailing financial results for the quarter ended September 30, 2024. While the filing itself does not contain the detailed financial figures, it directs investors to Exhibit 99.1, the accompanying press release, for this crucial information. Investors should refer to this press release to understand the company's performance during the third quarter of 2024, including revenue, profitability, and any forward-looking guidance provided by management.

Astera Labs, Inc. reported significant revenue growth in the second quarter of 2024, with revenues reaching $76.9 million, a substantial increase of 619% compared to the same period last year. This growth was primarily driven by strong demand for its Aries products, coupled with an increased mix of higher-priced second-generation products. Despite this revenue surge, the company reported a net loss of $7.5 million for the quarter, although this is an improvement from the $20.0 million net loss in Q2 2023. The company's gross margin remained strong at 77.9% for the quarter. The significant increase in operating expenses, particularly research and development and sales and marketing, is largely attributable to a substantial rise in non-cash stock-based compensation expense following the company's Initial Public Offering (IPO) in March 2024. The company successfully completed its IPO, raising $672.2 million in net proceeds, which significantly bolstered its cash position to $831.0 million in cash, cash equivalents, and marketable securities as of June 30, 2024. Management believes this liquidity is sufficient for at least the next 12 months.

Astera Labs, Inc. (ALAB) filed an 8-K on August 6, 2024, primarily to announce its financial results for the quarter ended June 30, 2024, via a press release furnished as Exhibit 99.1. This filing also signals a significant event for investors: the impending expiration of the lock-up period for company insiders and early investors. The restrictions on selling or transferring shares are set to terminate on August 8, 2024, following the earnings announcement. This upcoming expiration of the lock-up period means that a substantial number of shares held by officers, directors, and major pre-IPO stockholders will become available for trading. Investors should monitor the trading activity around this date as it could introduce increased selling pressure and impact share price volatility. While the press release contains the company's financial performance for the recent quarter, the 8-K filing itself focuses on the procedural aspects of announcing these results and the consequential termination of the lock-up agreements.

Astera Labs, Inc. (ALAB) has announced a strategic expansion of its Board of Directors, appointing Bethany Mayer as an independent director. This move, effective June 23, 2024, increases the Board size from six to seven members and enhances the composition of its Audit Committee. Ms. Mayer brings a wealth of experience from leadership roles at major technology and energy companies, including HP, Ixia, and Sempra Energy, and currently serves on the boards of Hewlett Packard Enterprise, Box, Inc., and LAM Research Corporation. Her appointment is expected to bring valuable expertise to Astera Labs, particularly in technology, corporate governance, and audit matters. Ms. Mayer will receive customary director compensation, including a prorated annual retainer for her board and audit committee service, and will be granted a one-time restricted stock unit award valued at $330,000, vesting over three years. This addition signals a commitment to strengthening board oversight and leveraging experienced leadership as the company continues its growth trajectory.

Astera Labs, Inc. (ALAB) reported strong revenue growth in the first quarter of 2024, with revenue increasing 269% year-over-year to $65.3 million, primarily driven by demand for its Aries product and a 20% increase in average selling prices. The company also saw a significant improvement in gross margin, expanding by 53.3 percentage points to 77.4%, attributed to higher selling prices and the absence of a prior year inventory write-down. Despite the impressive top-line growth and margin expansion, Astera Labs continues to operate at a net loss, reporting a net loss of $93.0 million for the quarter. This loss was significantly impacted by increased operating expenses, particularly a substantial rise in stock-based compensation expense related to the company's recent Initial Public Offering (IPO). The company completed its IPO on March 22, 2024, raising $672.2 million in net proceeds. While the company's cash position has strengthened considerably post-IPO, investors should monitor the path to profitability amidst ongoing investments in research and development and sales and marketing.

Astera Labs, Inc. (ALAB) filed an 8-K on May 7, 2024, primarily to furnish a press release detailing its financial results for the first quarter ended March 31, 2024. While the 8-K itself does not contain the detailed financial figures, it directs investors to the accompanying press release (Exhibit 99.1) for this information. This is a standard disclosure mechanism for companies to announce earnings. Investors should refer to the furnished press release for specific revenue, profitability, and guidance metrics. The key takeaway for investors is that this filing serves as the official notification of the company's quarterly performance announcement. The press release, as referenced in the filing, would contain the operational and financial condition updates, including any forward-looking statements or management commentary on business trends. The 8-K structure indicates that the detailed financial data is not presented directly in the filing itself but is made available through the referenced exhibit, which is a common practice for timely reporting of earnings.

Astera Labs, Inc. (ALAB) has filed an 8-K to provide an update on its post-Initial Public Offering (IPO) lock-up agreements. A significant portion of shares held by certain employees, referred to as "Early Release Shares," will become eligible for sale on May 9, 2024. This early release is contingent upon the satisfaction of a specific stock price performance condition, which has been met. The company will announce its first-quarter 2024 financial results on May 7, 2024, after market close. While this early unlock for a portion of employee shares is a key development, it's crucial for investors to note that lock-up restrictions remain in place for all other shares held by officers, directors, and other significant stockholders until the original lock-up period expires. This original period ends on the earlier of 180 days from March 19, 2024, or the second trading day following the company's earnings release for the quarter ending June 30, 2024. Investors should monitor potential selling pressure from the ~20% of eligible employee shares becoming available.

This 8-K filing from Astera Labs, Inc. (ALAB) primarily details the completion of its Initial Public Offering (IPO) on March 22, 2024. The company successfully offered 22,770,000 shares of Common Stock at an initial price of $36.00 per share. Of these, 19,758,903 shares were sold by Astera Labs itself, including the full exercise of the underwriters' option for an additional 2,970,000 shares. Certain selling stockholders also sold 3,011,097 shares, with the company not receiving proceeds from those sales. Furthermore, the filing confirms the automatic conversion of all outstanding preferred stock into 90,890,650 shares of common stock, which occurred immediately prior to the IPO's closing. This conversion was conducted on a one-for-one basis and was not registered under the Securities Act of 1933, relying on an exemption for unregistered sales of equity securities. The company also updated its corporate governance documents, filing an amended and restated certificate of incorporation and bylaws, effective upon the IPO's consummation.